Last reviewed · How we verify

NCT06138847: levcbz

Does Levetiracetam and Carbamazepine Impact the Autonomic Activity of Children With Self-limiting Focal Epilepsy?

Status unknown Last updated 18 November 2023
What this trial tests

trial testing electroencephalogram in Epilepsy; Syndrome, Seizures of Localized Onset in 119 participants. Status unknown.

Timeline
1 January 2023
Primary endpoint
1 August 2023
2 December 2023

Quick facts

Lead sponsorİpek Dokurel
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment119
Start date1 January 2023
Primary completion1 August 2023
Estimated completion2 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

İpek Dokurel

Who can join

Adults 5 to 17, any sex, with Epilepsy; Syndrome, Seizures of Localized Onset. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this cross-sectional study is to learn about autonomic cardiac profile changes in children with self-limiting focal epilepsy using levetiracetam and carbamazepine in children with self-limiting focal epilepsy syndrome. The main questions is it aims to answer are: 1. Are heart rate variability and autonomic tone different among healthy controls and children with epilepsy? 2. Does Levetiracetam and carbamazepine affect autonomic tone differently among children with self-limiting focal epilepsy?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of electroencephalogram

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06138847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing